Komori
Sumitomo Seika Chemicals Company,Limited. (4008) · InitiativeRestatedLatest Dividends (2026-08-06): "Reframed"

Investing retained earnings in production systems, cost competitiveness and research and development

First written in FY2017. 3 of 5 entries say "Restated". Latest entry: 2026-08-06.

5entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20222017: 120172018: 120182019: 020192020: 020202021: 120212022: 120222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
Strategic Allocation of Retained Earnings to Growth InvestmentA theme 49 companies write about · 0 as a headwind · 49 as a tailwind

Sumitomo Seika Chemicals Company,Limited. moved to the "Worse" side of this theme in 2026, 4 years after the typical company in this theme (2022).

The whole theme swung hardest in 2022: 3 of 23 companies on the "Worse" side.

3 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 49 companies compared. The sentences above are computed from all 49.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-06ReframedDividends

    「Retained earnings will be allocated to growth investment and strengthening the management foundation.」

    The stated use of retained earnings was reorganized from investment in expanding production capacity, strengthening cost competitiveness and product research and development to growth investment and strengthening the management foundation.
  2. FY2022RestatedAnnual report

    「The Company plans to invest retained earnings in expanding production capacity, strengthening cost competitiveness and conducting R&D on products that meet market needs, all of which will contribute to improved performance and a stronger management base.」

    The policy of investing retained earnings in production capacity, cost competitiveness and R&D remains in place.
  3. FY2021RestatedAnnual report

    「The Company plans to invest retained earnings in expanding production capacity, strengthening cost competitiveness and conducting R&D on products that meet market needs, all of which will contribute to improved performance and a stronger management base.」

    The policy of investing retained earnings in production capacity, cost competitiveness and R&D remains in place.
  4. FY2018RestatedAnnual report

    「The Company plans to invest retained earnings in expanding production capacity, strengthening cost competitiveness and conducting R&D on products that meet market needs, all of which will contribute to improved performance and a stronger management base.」

    The policy of investing retained earnings in production capacity, cost competitiveness and R&D remains in place.
  5. FY2017First statedAnnual report

    「The Company plans to invest retained earnings in expanding production capacity, strengthening cost competitiveness and conducting R&D on products that meet market needs, all of which will contribute to improved performance and a stronger management base.」

    The Company has stated its policy of allocating retained earnings to production capacity, cost competitiveness and product R&D.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sumitomo Seika Chemicals Company,Limited. yet. It last moved in the Dividends of 2026-08-06: "Reframed".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Investing retained earnings in production systems, cost competitiveness and research and development | Sumitomo Seika Chemicals Company,Limited. (4008) | Komori